| Year |
Citation |
Score |
| 2023 |
Santoscoy MC, Espinoza P, De La Cruz D, Mahamdeh M, Starr JR, Patel N, Maguire CA. An AAV capsid increases transduction of striatum and a ChAT promoter allows selective cholinergic neuron transduction. Molecular Therapy. Methods & Clinical Development. 29: 532-540. PMID 37359416 DOI: 10.1016/j.omtm.2023.05.001 |
0.343 |
|
| 2022 |
Prabhakar S, Beauchamp RL, Cheah PS, Yoshinaga A, Haidar EA, Lule S, Mani G, Maalouf K, Stemmer-Rachamimov A, Jung DH, Welling DB, Giovannini M, Plotkin SR, Maguire CA, Ramesh V, et al. Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2. Molecular Therapy. Methods & Clinical Development. 26: 169-180. PMID 35846573 DOI: 10.1016/j.omtm.2022.06.012 |
0.533 |
|
| 2022 |
Ahmed SG, Maguire CA, Cao SA, Brenner GJ. Schwannoma Gene Therapy via Adeno-Associated Viral Vector Delivery of Apoptosis-Associated Speck-like Protein Containing CARD (ASC): Preclinical Efficacy and Safety. International Journal of Molecular Sciences. 23. PMID 35055004 DOI: 10.3390/ijms23020819 |
0.316 |
|
| 2021 |
Cheng M, Dietz L, Gong Y, Eichler F, Nammour J, Ng C, Grimm D, Maguire CA. Neutralizing antibody evasion and transduction with purified extracellular vesicle-enveloped AAV vectors. Human Gene Therapy. PMID 34445894 DOI: 10.1089/hum.2021.122 |
0.316 |
|
| 2021 |
Ivanchenko MV, Hanlon KS, Hathaway DM, Klein AJ, Peters CW, Li Y, Tamvakologos PI, Nammour J, Maguire CA, Corey DP. AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear. Molecular Therapy. Methods & Clinical Development. 21: 382-398. PMID 33869656 DOI: 10.1016/j.omtm.2021.03.019 |
0.351 |
|
| 2021 |
Peters CW, Maguire CA, Hanlon KS. Delivering AAV to the Central Nervous and Sensory Systems. Trends in Pharmacological Sciences. PMID 33863599 DOI: 10.1016/j.tips.2021.03.004 |
0.33 |
|
| 2021 |
Cheah PS, Prabhakar S, Yellen D, Beauchamp RL, Zhang X, Kasamatsu S, Bronson RT, Thiele EA, Kwiatkowski DJ, Stemmer-Rachamimov A, György B, Ling KH, Kaneki M, Tannous BA, Ramesh V, ... Maguire CA, et al. Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin. Science Advances. 7. PMID 33523984 DOI: 10.1126/sciadv.abb1703 |
0.529 |
|
| 2020 |
Xia Y, He J, Zhang H, Wang H, Tetz G, Maguire CA, Wang Y, Onuma A, Genkin D, Tetz V, Stepanov A, Terekhov S, Ukrainskaya V, Huang H, Tsung A. AAV-mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response. Molecular Oncology. PMID 32813937 DOI: 10.1002/1878-0261.12787 |
0.362 |
|
| 2020 |
Griciuc A, Federico AN, Natasan J, Forte AM, McGinty D, Nguyen H, Volak A, LeRoy S, Gandhi S, Lerner EP, Hudry E, Tanzi RE, Maguire CA. Gene therapy for Alzheimer's Disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Human Molecular Genetics. PMID 32803224 DOI: 10.1093/Hmg/Ddaa179 |
0.317 |
|
| 2020 |
Maguire CA, Corey DP. Viral vectors for gene delivery to the inner ear. Hearing Research. 107927. PMID 32199720 DOI: 10.1016/J.Heares.2020.107927 |
0.435 |
|
| 2020 |
Breuer CB, Hanlon KS, Natasan JS, Volak A, Meliani A, Mingozzi F, Kleinstiver BP, Moon JJ, Maguire CA. In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery. Scientific Reports. 10: 4544. PMID 32161326 DOI: 10.1038/S41598-020-61518-W |
0.467 |
|
| 2020 |
Ivanchenko MV, Hanlon KS, Devine MK, Tenneson K, Emond F, Lafond JF, Kenna MA, Corey DP, Maguire CA. Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochlea. Hearing Research. 107930. PMID 32145977 DOI: 10.1016/J.Heares.2020.107930 |
0.406 |
|
| 2019 |
Hanlon KS, Meltzer JC, Buzhdygan T, Cheng MJ, Sena-Esteves M, Bennett RE, Sullivan TP, Razmpour R, Gong Y, Ng C, Nammour J, Maiz D, Dujardin S, Ramirez SH, Hudry E, ... Maguire CA, et al. Selection of an Efficient AAV Vector for Robust CNS Transgene Expression. Molecular Therapy. Methods & Clinical Development. 15: 320-332. PMID 31788496 DOI: 10.1016/J.Omtm.2019.10.007 |
0.407 |
|
| 2019 |
Hanlon KS, Kleinstiver BP, Garcia SP, Zaborowski MP, Volak A, Spirig SE, Muller A, Sousa AA, Tsai SQ, Bengtsson NE, Lööv C, Ingelsson M, Chamberlain JS, Corey DP, Aryee MJ, ... ... Maguire CA, et al. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nature Communications. 10: 4439. PMID 31570731 DOI: 10.1038/S41467-019-12449-2 |
0.53 |
|
| 2019 |
Prabhakar S, Cheah PS, Zhang X, Zinter M, Gianatasio M, Hudry E, Bronson RT, Kwiatkowski DJ, Stemmer-Rachamimov A, Maguire CA, Sena-Esteves M, Tannous BA, Breakefield XO. Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. Molecular Therapy. Methods & Clinical Development. 15: 18-26. PMID 31534984 DOI: 10.1016/J.Ibror.2019.07.1575 |
0.559 |
|
| 2019 |
Ahmed SG, Ahmed A, Maguire CA, Doha M, Sagers J, Lewis RM, Muzikansky A, Giovannini M, Stemmer-Rachamimov A, Stankovic KM, Fulci G, Brenner GJ. Gene therapy with apoptosis-associated speck-like protein (ASC), a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo. Neuro-Oncology. PMID 30977509 DOI: 10.1093/Neuonc/Noz065 |
0.365 |
|
| 2019 |
György B, Meijer EJ, Ivanchenko MV, Tenneson K, Emond F, Hanlon KS, Indzhykulian AA, Volak A, Karavitaki KD, Tamvakologos PI, Vezina M, Berezovskii VK, Born RT, O'Brien M, Lafond JF, ... ... Maguire CA, et al. Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate. Molecular Therapy. Methods & Clinical Development. 13: 1-13. PMID 30581889 DOI: 10.1016/J.Omtm.2018.11.003 |
0.428 |
|
| 2018 |
Gong Y, Berenson A, Laheji F, Gao G, Wang D, Ng C, Volak A, Kok R, Kreouzis V, Dijkstra I, Kemp S, Maguire CA, Eichler F. Intrathecal Adeno-Associated Virus Vector-mediated Gene Delivery for Adrenomyeloneuropathy. Human Gene Therapy. PMID 30358470 DOI: 10.1089/Hum.2018.079 |
0.406 |
|
| 2018 |
Hudry E, Andres-Mateos E, Lerner EP, Volak A, Cohen O, Hyman BT, Maguire CA, Vandenberghe LH. Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65. Molecular Therapy. Methods & Clinical Development. 10: 197-209. PMID 30109242 DOI: 10.1016/J.Omtm.2018.07.006 |
0.657 |
|
| 2018 |
György B, Lööv C, Zaborowski MP, Takeda S, Kleinstiver BP, Commins C, Kastanenka K, Mu D, Volak A, Giedraitis V, Lannfelt L, Maguire CA, Joung JK, Hyman BT, Breakefield XO, et al. CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease. Molecular Therapy. Nucleic Acids. 11: 429-440. PMID 29858078 DOI: 10.1016/J.Omtn.2018.03.007 |
0.504 |
|
| 2018 |
Volak A, LeRoy SG, Natasan JS, Park DJ, Cheah PS, Maus A, Fitzpatrick Z, Hudry E, Pinkham K, Gandhi S, Hyman BT, Mu D, GuhaSarkar D, Stemmer-Rachamimov AO, Sena-Esteves M, ... ... Maguire CA, et al. Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery. Journal of Neuro-Oncology. PMID 29767307 DOI: 10.1007/S11060-018-2889-2 |
0.414 |
|
| 2017 |
Meliani A, Boisgerault F, Fitzpatrick Z, Marmier S, Leborgne C, Collaud F, Simon Sola M, Charles S, Ronzitti G, Vignaud A, van Wittenberghe L, Marolleau B, Jouen F, Tan S, Boyer O, ... ... Maguire CA, et al. Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors. Blood Advances. 1: 2019-2031. PMID 29296848 DOI: 10.1182/Bloodadvances.2017010181 |
0.44 |
|
| 2017 |
György B, Maguire CA. Extracellular vesicles: nature's nanoparticles for improving gene transfer with adeno-associated virus vectors. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 28799250 DOI: 10.1002/Wnan.1488 |
0.466 |
|
| 2017 |
Wassmer SJ, Carvalho LS, György B, Vandenberghe LH, Maguire CA. Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection. Scientific Reports. 7: 45329. PMID 28361998 DOI: 10.1038/Srep45329 |
0.66 |
|
| 2017 |
György B, Sage C, Indzhykulian AA, Scheffer DI, Brisson AR, Tan S, Wu X, Volak A, Mu D, Tamvakologos PI, Li Y, Fitzpatrick Z, Ericsson M, Breakefield XO, Corey DP, ... Maguire CA, et al. Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28082074 DOI: 10.1016/J.Ymthe.2016.12.010 |
0.59 |
|
| 2016 |
Dashkoff J, Lerner EP, Truong N, Klickstein JA, Fan Z, Mu D, Maguire CA, Hyman BT, Hudry E. Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9. Molecular Therapy. Methods & Clinical Development. 3: 16081. PMID 27933308 DOI: 10.1038/Mtm.2016.81 |
0.418 |
|
| 2016 |
Merkel SF, Andrews AM, Lutton EM, Mu D, Hudry E, Hyman BT, Maguire CA, Ramirez SH. Trafficking of AAV vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells. Journal of Neurochemistry. PMID 27718541 DOI: 10.1111/Jnc.13861 |
0.422 |
|
| 2016 |
Crommentuijn MH, Kantar R, Noske DP, Vandertop WP, Badr CE, Würdinger T, Maguire CA, Tannous BA. Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model. Molecular Therapy Oncolytics. 3: 16017. PMID 27382645 DOI: 10.1038/Mto.2016.17 |
0.467 |
|
| 2016 |
Choudhury SR, Fitzpatrick Z, Harris AF, Maitland SA, Ferreira JS, Zhang Y, Ma S, Sharma RB, Gray-Edwards HL, Johnson JA, Johnson AK, Alonso LC, Punzo C, Wagner KR, Maguire CA, et al. In vivo selection yields AAV-B1 capsid for CNS and muscle gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27117222 DOI: 10.1038/Mt.2016.84 |
0.443 |
|
| 2016 |
Zappulli V, Friis KP, Fitzpatrick Z, Maguire CA, Breakefield XO. Extracellular vesicles and intercellular communication within the nervous system. The Journal of Clinical Investigation. 126: 1198-207. PMID 27035811 DOI: 10.1172/Jci81134 |
0.489 |
|
| 2016 |
Choudhury SR, Hudry E, Maguire CA, Sena-Esteves M, Breakefield XO, Grandi P. Viral vectors for therapy of neurologic diseases. Neuropharmacology. PMID 26905292 DOI: 10.1016/J.Neuropharm.2016.02.013 |
0.546 |
|
| 2016 |
Hudry E, Martin C, Gandhi S, György B, Scheffer DI, Mu D, Merkel SF, Mingozzi F, Fitzpatrick Z, Dimant H, Masek M, Ragan T, Tan S, Brisson AR, Ramirez SH, ... ... Maguire CA, et al. Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Therapy. PMID 26836117 DOI: 10.1038/Gt.2016.11 |
0.506 |
|
| 2016 |
Hudry E, Dashkoff J, Lerner P, Takeda S, Truong N, Maguire C, Hyman BT. 616. Tailored Expression of a Transgene to Specific Cell Types in the Central Nervous System After Peripheral Injection of AAV9 Molecular Therapy. 24: S244. DOI: 10.1016/S1525-0016(16)33424-4 |
0.446 |
|
| 2016 |
Meliani A, Fitzpatrick Z, Boisgerault F, Ronzitti G, Collaud F, Charles S, Maguire CA, Mingozzi F. 595. Enhanced Liver Transduction and Efficient Protection from Pre-Existing Neutralizing Antibodies with Exosome-Associated AAV8 Vectors Molecular Therapy. 24: S235-S236. DOI: 10.1016/S1525-0016(16)33403-7 |
0.444 |
|
| 2016 |
György B, Wassmer S, Carvalho L, Maguire C, Vandenberghe LH. 594. Exosome-Associated AAV Enhances Retinal Transduction Following Intravitreal Injection Molecular Therapy. 24: S235. DOI: 10.1016/S1525-0016(16)33402-5 |
0.635 |
|
| 2015 |
Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Del Portillo HA, O'Driscoll L, Fais S, Falcon-Perez JM, Felderhoff-Mueser U, Fraile L, ... ... Maguire CA, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. Journal of Extracellular Vesicles. 4: 30087. PMID 26725829 DOI: 10.3402/Jev.V4.30087 |
0.345 |
|
| 2015 |
Crommentuijn MH, Maguire CA, Niers JM, Vandertop WP, Badr CE, Würdinger T, Tannous BA. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma. Molecular Oncology. PMID 26708508 DOI: 10.1016/J.Molonc.2015.11.011 |
0.368 |
|
| 2015 |
Balaj L, Atai NA, Chen W, Mu D, Tannous BA, Breakefield XO, Skog J, Maguire CA. Heparin affinity purification of extracellular vesicles. Scientific Reports. 5: 10266. PMID 25988257 DOI: 10.1038/Srep10266 |
0.486 |
|
| 2015 |
Gong Y, Mu D, Prabhakar S, Moser A, Musolino P, Ren J, Breakefield XO, Maguire CA, Eichler FS. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 824-34. PMID 25592337 DOI: 10.1038/Mt.2015.6 |
0.595 |
|
| 2015 |
Ahmed SG, Hadaegh F, Sena-Esteves M, Maguire CA, Fulci G, Breakefield XO, Brenner GJ. 635. Mechanisms of Caspase-1 Mediated Schwannoma Regression Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)34244-7 |
0.565 |
|
| 2015 |
Gong Y, Mu D, Ren J, Moser A, Maguire CA, Eichler FS. 390. Impact of rAAV9-ABCD1 Upon Behavioral Outcome in a Mouse Model of X-ALD Molecular Therapy. 23: S155. DOI: 10.1016/S1525-0016(16)33999-5 |
0.348 |
|
| 2015 |
Hudry EM, Martin C, Mu D, Mingozzi F, Hyman BT, Maguire CA. 312. Highly-Efficient CNS Transduction With Vesicle-Associated AAV Vector Molecular Therapy. 23: S126. DOI: 10.1016/S1525-0016(16)33921-1 |
0.47 |
|
| 2015 |
Meliani A, Fitzpatrick Z, Charles S, Mu D, Boisgerault F, Maguire CA, Mingozzi F. 311. AAV8 Vexosome Vectors Enhance Cell Transduction In Vitro and Outperform Conventional AAV8 Vectors in Liver-Transduction In Vivo in the Presence of Anti-AAV Neutralizing Antibodies Molecular Therapy. 23: S125-S126. DOI: 10.1016/S1525-0016(16)33920-X |
0.437 |
|
| 2015 |
Fitzpatrick Z, Maus A, Gyorgy B, Mu D, Csomos K, Walter JE, Maguire CA. 266. G-Force Loading of Virus Vectors into Vesicles for Enhanced Gene Therapy Vehicles Molecular Therapy. 23: S106. DOI: 10.1016/S1525-0016(16)33875-8 |
0.453 |
|
| 2015 |
Carvalho LS, György B, Mu D, Shah S, Vandenberghe LH, Maguire CA. 152. Retinal Tropism of Exosome-Associated AAV Vector Via Intravitreal Delivery Molecular Therapy. 23: S61. DOI: 10.1016/S1525-0016(16)33757-1 |
0.666 |
|
| 2015 |
Gyorgy B, Sage C, Scheffer D, Indzhykulian AA, Mu D, Breakefield XO, Maguire CA, Corey DP. 16. Exosome-Associated AAV as a Novel Platform for Gene Therapy of Hearing Loss Molecular Therapy. 23: S7. DOI: 10.1016/S1525-0016(16)33620-6 |
0.577 |
|
| 2014 |
Fitzpatrick Z, György B, Skog J, Maguire CA. Extracellular vesicles as enhancers of virus vector-mediated gene delivery. Human Gene Therapy. 25: 785-6. PMID 25244570 DOI: 10.1089/Hum.2014.082 |
0.43 |
|
| 2014 |
Maguire CA, Ramirez SH, Merkel SF, Sena-Esteves M, Breakefield XO. Gene therapy for the nervous system: challenges and new strategies. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 817-39. PMID 25159276 DOI: 10.1007/S13311-014-0299-5 |
0.566 |
|
| 2014 |
György B, Fitzpatrick Z, Crommentuijn MH, Mu D, Maguire CA. Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo. Biomaterials. 35: 7598-609. PMID 24917028 DOI: 10.1016/J.Biomaterials.2014.05.032 |
0.421 |
|
| 2014 |
Lai CP, Mardini O, Ericsson M, Prabhakar S, Maguire CA, Chen JW, Tannous BA, Breakefield XO. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. Acs Nano. 8: 483-94. PMID 24383518 DOI: 10.1021/Nn404945R |
0.53 |
|
| 2014 |
Maguire CA. Bioluminescence-based monitoring of virus vector-mediated gene transfer in mice. Methods in Molecular Biology (Clifton, N.J.). 1098: 197-209. PMID 24166379 DOI: 10.1007/978-1-62703-718-1_16 |
0.457 |
|
| 2013 |
Atai NA, Balaj L, van Veen H, Breakefield XO, Jarzyna PA, Van Noorden CJ, Skog J, Maguire CA. Heparin blocks transfer of extracellular vesicles between donor and recipient cells. Journal of Neuro-Oncology. 115: 343-51. PMID 24002181 DOI: 10.1007/S11060-013-1235-Y |
0.505 |
|
| 2013 |
Maguire CA, Crommentuijn MH, Mu D, Hudry E, Serrano-Pozo A, Hyman BT, Tannous BA. Mouse gender influences brain transduction by intravascularly administered AAV9. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1470-1. PMID 23903572 DOI: 10.1038/Mt.2013.95 |
0.365 |
|
| 2013 |
Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA, Loguidice L, Soto H, Garrett M, Zhu LD, Sivaraman S, Chen C, Wong ET, Carter BS, Hochberg FH, et al. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Molecular Therapy. Nucleic Acids. 2: e109. PMID 23881452 DOI: 10.1038/Mtna.2013.28 |
0.465 |
|
| 2013 |
Maguire CA, Bovenberg MS, Crommentuijn MH, Niers JM, Kerami M, Teng J, Sena-Esteves M, Badr CE, Tannous BA. Triple bioluminescence imaging for in vivo monitoring of cellular processes. Molecular Therapy. Nucleic Acids. 2: e99. PMID 23778500 DOI: 10.1038/Mtna.2013.25 |
0.36 |
|
| 2012 |
Maguire CA, van der Mijn JC, Degeling MH, Morse D, Tannous BA. Codon-optimized Luciola italica luciferase variants for mammalian gene expression in culture and in vivo. Molecular Imaging. 11: 13-21. PMID 22418023 DOI: 10.2310/7290.2011.00022 |
0.416 |
|
| 2012 |
Maguire CA, Balaj L, Sivaraman S, Crommentuijn MH, Ericsson M, Mincheva-Nilsson L, Baranov V, Gianni D, Tannous BA, Sena-Esteves M, Breakefield XO, Skog J. Microvesicle-associated AAV vector as a novel gene delivery system. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 960-71. PMID 22314290 DOI: 10.1038/Mt.2011.303 |
0.592 |
|
| 2010 |
Maguire CA, Gianni D, Meijer DH, Shaket LA, Wakimoto H, Rabkin SD, Gao G, Sena-Esteves M. Directed evolution of adeno-associated virus for glioma cell transduction. Journal of Neuro-Oncology. 96: 337-47. PMID 19618115 DOI: 10.1007/S11060-009-9972-7 |
0.471 |
|
| 2009 |
Maguire CA, Deliolanis NC, Pike L, Niers JM, Tjon-Kon-Fat LA, Sena-Esteves M, Tannous BA. Gaussia luciferase variant for high-throughput functional screening applications. Analytical Chemistry. 81: 7102-6. PMID 19601604 DOI: 10.1021/Ac901234R |
0.327 |
|
| 2009 |
Meijer DH, Maguire CA, LeRoy SG, Sena-Esteves M. Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta. Cancer Gene Therapy. 16: 664-71. PMID 19197327 DOI: 10.1038/Cgt.2009.8 |
0.381 |
|
| 2008 |
Maguire CA, Meijer DH, LeRoy SG, Tierney LA, Broekman ML, Costa FF, Breakefield XO, Stemmer-Rachamimov A, Sena-Esteves M. Preventing growth of brain tumors by creating a zone of resistance. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1695-702. PMID 18714312 DOI: 10.1038/Mt.2008.168 |
0.546 |
|
| 2007 |
Sapinoro R, Maguire CA, Burgess A, Dewhurst S. Enhanced transduction of dendritic cells by FcgammaRI-targeted adenovirus vectors. The Journal of Gene Medicine. 9: 1033-45. PMID 17966114 DOI: 10.1002/Jgm.1112 |
0.367 |
|
| 2006 |
Maguire CA, Sapinoro R, Girgis N, Rodriguez-Colon SM, Ramirez SH, Williams J, Dewhurst S. Recombinant adenovirus type 5 vectors that target DC-SIGN, ChemR23 and alpha(v)beta3 integrin efficiently transduce human dendritic cells and enhance presentation of vectored antigens. Vaccine. 24: 671-82. PMID 16154247 DOI: 10.1016/J.Vaccine.2005.08.038 |
0.339 |
|
| 2005 |
Fan S, Maguire CA, Ramirez SH, Bradel-Tretheway B, Sapinoro R, Sui Z, Chakraborty-Sett S, Dewhurst S. Valproic acid enhances gene expression from viral gene transfer vectors. Journal of Virological Methods. 125: 23-33. PMID 15737413 DOI: 10.1016/J.Jviromet.2004.11.023 |
0.454 |
|
| Show low-probability matches. |